Table 2.
Experimental days with highest clinical scoring after inoculation of goats with goatpox virus (n = 8) and controls (n = 2)
| Goat no. | Group 1a | Group 2a | Group 3a | Control | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 129 | 335 | 373 | 269 | 287 | 261 | 752 | 265 | 759 | 267 | |
| Score | ||||||||||
| Post-infection day of highest score | 16 | 16 | 16 | 18 | 18 | 18 | 18 | 18 | 12 | 17 |
| Behavior | 3 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 0 |
| Feed-intake | 2 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Nodule at injection site | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 0 | 0 |
| Temperature | 4 | 4 | 4 | 3 | 1 | 2 | 1 | 1 | 0 | 0 |
| Cutaneous lesions | 5 | 5 | 5 | 5 | 5 | 5 | 3 | 3 | 0 | 0 |
| Oculo-nasal discharge | 3 | 3 | 3 | 2 | 2 | 2 | 1 | 1 | 0 | 1 |
| Salivation | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total clinical scoring | 22 | 22 | 22 | 16 | 13 | 13 | 8 | 8 | 1 | 1 |
aGroup 1, Group 2, Group 3: Inoculated goats were retrospectively divided into 3 groups, based on severity of clinical signs at the end of the experiment